Bausch Health Companies Inc. cotiza a 5.89 USD y tiene una capitalización bursátil de $2.2B. En los últimos 12 meses ha facturado $10.9B con un margen de flujo de caja libre del 9.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterol…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $1.26 | $0.78 | $1.10 |
| Estimado | $1.24 | $1.01 | $0.69 | $1.26 |
| Sorpresa | — | +24.8% | +13.0% | -12.7% |
| Métrica | BHC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 17.7% | -38.6% | +56.3% |
| Net Margin | 1.5% | -33.6% | +35.1% |
| FCF Margin | 9.8% | -13.9% | +23.6% |
| ROE | — | -40.4% | — |
| ROA | 0.6% | -32.0% | +32.6% |
| Current Ratio | 1.47 | 2.84 | -1.37 |
| Debt / Equity | -37.58 | 0.28 | -37.86 |